Form 4 for PFE Pfizer
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-25 · accession 0001225208-23-002987 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-28 | 2023-02-25+ | PFE | McDermott Michael | EVP | F - Tax | $42.38 | -12.2K | 84.0K | -13% | -$518.1K |
| D | 2023-02-28 | 2023-02-25 | PFE | McDermott Michael | EVP | M - OptEx | $22.89 | +14.2K | 93.1K | +18% | +$324.5K |
| D | 2023-02-28 | 2023-02-25 | PFE | McDermott Michael | EVP | M - OptEx | $0.00 | -14.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-27 | F | D | 3,081 | $40.78 | 80,874 | D | — | — | (F6) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |
| 2 | Common | Common Stock | 2023-02-25 | F | D | 2,839 | $41.75 | 90,260 | D | — | — | (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. (F3) Price is the closing price of Pfizer common stock on February 24, 2023. |
| 3 | Common | Common Stock | 2023-02-25 | M | A | 14,178 | $22.89 | 93,099 | D | — | — | (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| 4 | Common | Common Stock | 2023-02-25 | F | D | 6,305 | $43.44 | 83,955 | D | — | — | (F4) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F5) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| 5 | Derivative | Stock Appreciation Rights | 2023-02-25 | M | D | 14,178 | $0.00 | 0 | D | $22.89 · 2023-02-25 to 2023-02-25 | 14,178 Common Stock | (F7) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |